✦ LIBER ✦

Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias

✍ Scribed by Patrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, Nora Pällman, Melanie Braig, Valeska Wiehle, Susanne Ziegler, Marcus Schröder, Chris Meier, Adrian Kolodzik, Matthias Rarey, Jens Panse, Joachim Hauber, Stefan Balabanov, Tim H. Brümmendorf

Book ID: 118299102
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 635 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9810-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis-based dual molecular targeting

Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

✍ Kuroda, J; Kimura, S; Strasser, A; Andreeff, M; O'Reilly, L A; Ashihara, E; Kami 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 557 KB

The Bcr-Abl kinase inhibitor INNO-406 in

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias

✍ Kamitsuji, Y; Kuroda, J; Kimura, S; Toyokuni, S; Watanabe, K; Ashihara, E; Tanak 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 548 KB

Effect of a selective Abl tyrosine kinas

Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells

✍ Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 546 KB

Synergistic activity of the new ABL-spec

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

✍ Topaly, J; Zeller, W J; Fruehauf, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Treatment of Philadelphia-chromosome-pos

Treatment of Philadelphia-chromosome-positive human leukemia in scid mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor

✍ Yoshio Honma; Yoshinobu Matsuo; Yasuhide Hayashi; Satoshi Omura 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 731 KB

The molecular basis of the Philadelphia chromosome (Ph') is a structurally altered c-abl (bcr-abl) gene which encodes an abnormally large protein with protein tyrosine kinase activity. Herbimycin A, which effectively reduced intracellular phosphorylation by bcr-abl tyrosine kinase, preferentially in

Selective induction of apoptosis in Phil

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

✍ Dan, Shingo; Naito, Mikihiko; Tsuruo, Takashi 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB